Milae Bioresources Co. Ltd Cash Flow-to-Debt Ratio
Milae Bioresources Co. Ltd cash flow-to-debt ratio. Milae Bioresources Co. Ltd (218150) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of ₩-250.94 Million could theoretically repay 0% of its total liabilities (₩22.10 Billion) in one year. Check 218150 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Milae Bioresources Co. Ltd (2016–2025)
Cash flow-to-debt ratio of Milae Bioresources Co. Ltd from 2016 to 2025. Historical debt coverage capacity for Milae Bioresources Co. Ltd across 10 annual periods. Check Milae Bioresources Co. Ltd (218150) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Milae Bioresources Co. Ltd Cash Flow-to-Debt Ratio by Year (2016–2025)
Milae Bioresources Co. Ltd cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Milae Bioresources Co. Ltd. For the full cash flow conversion analysis, see Milae Bioresources Co. Ltd cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.27x | ₩4.40 Billion | ₩16.21 Billion | ▲ +671.0% |
| 2024 | -0.05x | ₩-966.33 Million | ₩20.32 Billion | ▼ -110.9% |
| 2023 | 0.43x | ₩3.23 Billion | ₩7.43 Billion | ▲ +459.7% |
| 2022 | 0.08x | ₩1.19 Billion | ₩15.35 Billion | ▼ -41.4% |
| 2021 | 0.13x | ₩2.98 Billion | ₩22.50 Billion | ▲ +34.6% |
| 2020 | 0.10x | ₩848.31 Million | ₩8.61 Billion | ▼ -75.5% |
| 2019 | 0.40x | ₩3.56 Billion | ₩8.86 Billion | ▲ +576.9% |
| 2018 | -0.08x | ₩-477.75 Million | ₩5.66 Billion | ▼ -112.7% |
| 2017 | 0.66x | ₩4.18 Billion | ₩6.30 Billion | ▲ +1228.3% |
| 2016 | 0.05x | ₩76.65 Million | ₩1.53 Billion | — |